Immunological aspects of cryosurgery in general surgery.
Existence and verification of the cryoimmunologic reaction are established in basic experiments and clinical studies. However, the most effective condition in which to elicit cryoimmunologic reaction is still unknown. Evidence suggests the necessity to intensify cryoimmune reaction, if we intend to use this as one of the specific immunotherapies clinically. Establishment of criteria to select patients receiving cryosurgery is another pending question. It is important to assess the patient's immunity or immunological competence prior to cryosurgery, thereby preventing immunologically induced aggravation after cryosurgery. Twelve years of clinical experience in cryosurgery was presented and analyzed. Overall 3-year survival in the primary cancer patients was 33.3%, and 5-year survival was 17.7%. It is our aim to achieve the most beneficial effects of cryosurgery for the patients with malignancies which would otherwise be difficult to treat by conventional means.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000818:Animals; D003452:Cryosurgery; D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000276:immunology / Q000601:surgery; D051379:Mice; D008875:Middle Aged; D009369:Neoplasms / Q000276:immunology* / Q000601:surgery; D009374:Neoplasms, Experimental / Q000276:immunology* / Q000601:surgery; D011817:Rabbits; D013964:Thyroid Neoplasms / Q000276:immunology / Q000601:surgery
D000276:Adjuvants, Immunologic